Cogent Biosciences (COGT) Interest Expenses (2025 - 2026)
Cogent Biosciences (COGT) recorded quarterly Interest Expenses of $1.2 million in Q1 2026, down 5.9% quarter-over-quarter from $1.3 million in Q4 2025.
Cogent Biosciences (COGT) Interest Expenses (2025 - 2026) Analysis & Trends
Cogent Biosciences' Interest Expenses history runs 2 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Interest Expenses changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $4.3 million (changed N/A YoY), while the FY2025 annual figure was $3.1 million, changed N/A from the prior year.
- Interest Expenses was $1.2 million for Q1 2026 at Cogent Biosciences, down from $1.3 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.5 million in Q3 2025 to a low of $314000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -5.58 Mn |
| 10 | Cogent Biosciences | 5.19 Bn | 4.32 Bn | - | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 314,000.00 |
| Jun 30, 2025 | 314,000.00 |